Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of MK-0752 in Pediatric Patients With Recurrent or Refractory CNS Malignancies

NCT00572182 is registered in ClinicalTrials.gov with Pediatric Brain Tumor Consortium as lead sponsor.

NCT NCT00572182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00572182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of MK-0752 in Pediatric Patients With Recurrent or Refractory CNS Malignancies
Lead sponsor
Pediatric Brain Tumor Consortium
Phase
Phase 1
Overall status
Terminated
Start date
July 31, 2008
Completion date
February 28, 2011
Enrollment
33 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors